5 completed, 3 not yet recruiting, 2 active not recruiting, 1 enrolling by invitation. 5 Phase 4, 2 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1 |
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Neuromuscular Blocking Agents: new trials by email Literature Review of Neuromuscular Blocking Agents trials Research Report on Neuromuscular Blocking Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antagonism of Neostigmine in Continuous Infusion of Mivacurium Neostigmine - Neuromuscular Blocking Agents | Not applicable | Not yet recruiting | Beijing Tongren Hospital | 120 | 2026-05-01 | 2026-04-13 |
| Study of the Relationship Between Curarization and Pneumoperitoneum in Laparoscopic Surgery No Intervention: Observational Cohort - Laparoscopic Surgery, Neuromuscular Blocking Agents | Not yet recruiting | Poitiers University Hospital | 200 | 2025-07-01 | 2025-06-18 | |
| Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Sevoflurane Anesthesia pipecuronium bromide, Rocuronium bromide - Neuromuscular Blocking Agents, Residual Neuromuscular Block | Phase 4 | Not yet recruiting | Tamas Vegh, MD | 80 | 2025-06-26 | 2025-06-29 |
| Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Propofol Anesthesia pipecuronium bromide, Rocuronium bromide - Neuromuscular Blocking Agents, Residual Neuromuscular Block | Phase 4 | Active not recruiting | Tamas Vegh, MD | 80 | 2025-06-26 | 2025-08-07 |
| NMBA Reversal and Postoperative Urinary Retention Choice of reversal agent (sugammadex or neostigmine [with muscaranic antagonist]) - Neuromuscular Blocking Agents, Urinary Retention After Procedure | Active not recruiting | Beth Israel Deaconess Medical Center | 70000 | 2025-06-08 | 2026-01-23 | |
| Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade Sugammadex 1 mg/kg, Neostigmine + Atropine - Neuromuscular Blocking Agents, Reversal of Neuromuscular Blockade | Phase 1 / Phase 2 | Recruiting | Universitas Padjadjaran | 60 | 2024-11-05 | 2025-01-28 |
| Neuromuscular Blocking Agents in Cardiac Surgery Neuromuscular blockade - Cardiac Surgery, Neuromuscular Blocking Agents | Completed | Erasme University Hospital | 39 | 2024-11-05 | 2025-05-21 | |
| Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants During Surgical Treatment of Craniosynostosis Sevofluorane, Propofol - Neuromuscular Blocking Agents, Residual Neuromuscular Block | Phase 4 | Enrolling by invitation | Tamas Vegh, MD | 20 | 2024-07-06 | 2025-08-05 |
| Management of Neuromuscular Blocking Agents and Their Antagonism Neuromuscular Blocking Agent - Neuromuscular Blocking Agents, Neuromuscular Monitoring | Unknown | Erasme University Hospital | 3000 | 2024-04-17 | 2024-04-19 | |
| Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex Neostigmine, Sugammadex - Urinary Retention Postoperative, Laparoscopic Cholecystectomy | Phase 4 | Completed | University of Texas Southwestern Medical Center | 235 | 2023-09-11 | 2024-10-09 |
| Reversal of Moderate or Superficial Neuromuscular Blockade Induced by Cisatracurium Reversal of moderate neuromuscular blockade, Reversal of superficial neuromuscular blockade, Two-step reversal - Neostigmine, Neuromuscular Blocking Agents | Phase 4 | Completed | Pontificia Universidade Catolica de Sao Paulo | 60 | 2021-06-01 | 2022-05-19 |
| Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety Deep neuromuscular block - Neuromuscular Blockade, Rocuronium | Not applicable | Completed | Leiden University Medical Center | 731 | 2020-02-11 | 2025-06-11 |
| Effect of Nitrous Oxide on Cisatracurium Infusion Demands Neuromuscular Blocking Agents | Completed | Turku University Hospital | 70 | 2007-04-01 | 2010-06-29 |
Delayed Emergence from Anesthesia (3) · Muscle Weakness (1) · Pneumoperitoneum (1) · Urinary Retention (1)
Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Postoperative Complications (3) · Digestive System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1) · Peritoneal Diseases (1) · Signs and Symptoms (1) · Urination Disorders (1)
Neostigmine (4) · Rocuronium (3) · Sugammadex (3) · Pipecuronium (2) · Atropine (1) · Muscle Relaxation (1) · Neuromuscular Blocking Agents (1) · Propofol (1)
Tamas Vegh, MD (3) · Erasme University Hospital (2) · Beijing Tongren Hospital (1) · Beth Israel Deaconess Medical Center (1) · Leiden University Medical Center (1) · Poitiers University Hospital (1) · Pontificia Universidade Catolica de Sao Paulo (1) · Turku University Hospital (1) · Universitas Padjadjaran (1) · University of Texas Southwestern Medical Center (1)
Hungary (3) · Belgium (2) · United States (2) · Brazil (1) · China (1) · Finland (1) · France (1) · Indonesia (1) · Italy (1) · Netherlands (1) · Spain (1)
Denis Schmartz, MD (1) · Eduardo T Moro, MD (1) · Guyan Wang (1) · Luca J Wachtendorf, MD (1) · Maximilian S Schaefer, MD, PhD (1) · Monique van Velzen, PhD (1) · Tiffany Moon, MD (1) · Tini T Maskoen, M.D. (1)